Published in Obstet Gynecol on November 01, 1985
Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69
Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1993) 2.96
Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol (1998) 2.72
Breast cancer in 3,558 women: age as a significant determinant in the rate of dying and causes of death. Surgery (1978) 2.65
Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol (1986) 2.41
The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens (2014) 2.29
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med (1996) 2.28
No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol (1996) 2.22
Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol (1986) 2.21
Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol (1990) 2.15
Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol (1996) 1.94
Perinatal morbidity associated with violence experienced by pregnant women. Am J Obstet Gynecol (1994) 1.83
The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol (1998) 1.81
Nurse practitioners in primary care iv. Impact of an interdisciplinary team on attitudes of a rural population. Can Med Assoc J (1975) 1.80
Surgery and anesthesia in Ontario. Can Med Assoc J (1977) 1.77
Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res (1999) 1.76
Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1999) 1.75
Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol (1995) 1.73
Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol (1993) 1.69
Surgical rates in the Canadian provinces, 1968 to 1972. Can J Surg (1976) 1.66
Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol (2000) 1.61
Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. Paediatr Perinat Epidemiol (2001) 1.61
Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (1996) 1.59
Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr (1989) 1.59
The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol (1996) 1.57
Drug abuse and other risk factors for physical abuse in pregnancy among white non-Hispanic, black, and Hispanic women. Am J Obstet Gynecol (1991) 1.50
The effect of capitated and fee-for-service remuneration on physician decision making in gynecology. Obstet Gynecol (1996) 1.50
Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol (2000) 1.50
The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol (1997) 1.50
Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol (1989) 1.49
A comparison of nonculture-dependent methods for detection of Chlamydia trachomatis infections in pregnant women. Obstet Gynecol (1987) 1.49
Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) Am J Obstet Gynecol (1992) 1.49
Recurrent acute fatty liver of pregnancy. Am J Obstet Gynecol (1990) 1.48
Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.48
Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol (1981) 1.48
1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J Med Chem (1995) 1.46
Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg (1999) 1.45
Early detection of preeclampsia. Am J Obstet Gynecol (1991) 1.44
Concordance for coronary risk factors among spouses. Circulation (1975) 1.44
Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol (2000) 1.38
Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol (1999) 1.35
Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol (1987) 1.32
Nurse practitioners in primary care. II. Prior attitudes of a rural population. Can Med Assoc J (1973) 1.32
St John's Wort: effect on CYP3A4 activity. Clin Pharmacol Ther (2000) 1.30
Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol (2000) 1.30
Late postpartum eclampsia revisited. Obstet Gynecol (1994) 1.30
Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol (1986) 1.29
Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol (2001) 1.29
Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol (1989) 1.29
Size-at-birth standards for an urban Canadian population. Can Med Assoc J (1984) 1.28
Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol (2001) 1.19
Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol (1983) 1.16
Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol (1994) 1.16
RIII S/J (H-2r). An inbred mouse strain with a massive deletion of T cell receptor V beta genes. J Exp Med (1989) 1.16
Treatment in an obstetric intensive care unit. Am J Obstet Gynecol (1990) 1.15
Postpartum ovarian vein thrombosis after vaginal delivery: a report of 11 cases. Obstet Gynecol (1995) 1.15
Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat. Neuroscience (2008) 1.14
Postpartum stroke: a twenty-year experience. Am J Obstet Gynecol (2000) 1.13
Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice. Proc Natl Acad Sci U S A (1992) 1.12
Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol (1984) 1.10
A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol (1994) 1.10
Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol (1991) 1.09
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol (2000) 1.09
Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol (1992) 1.09
Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol (1997) 1.09
Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol (1994) 1.08
Comparison of provincial surgical rates in 1968. Can J Surg (1975) 1.08
Determinants of size at birth in a Canadian population. Am J Obstet Gynecol (1984) 1.07
Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials (1996) 1.07
Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol (2000) 1.06
Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol (1997) 1.04
T cell activation is regulated by voltage-dependent and calcium-activated potassium channels. J Immunol (1996) 1.03
Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynecol (1975) 1.03
Hypertension in pregnancy: current concepts of preeclampsia. Annu Rev Med (1997) 1.03
Pelvic inflammatory disease isolates of Neisseria gonorrhoeae are distinguished by C1q-dependent virulence for newborn rats and by the sac-4 region. Infect Immun (1997) 1.03
Sacroiliitis associated with pyelonephritis in pregnancy. Obstet Gynecol (1995) 1.03
Neuropsychological effects of valproate in traumatic brain injury: a randomized trial. Neurology (2000) 1.03
The incidence of positive amniotic fluid cultures in patients preterm labor with intact membranes. Am J Obstet Gynecol (1989) 1.03
A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections. Obstet Gynecol Surv (1992) 1.02
Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol (1988) 1.02
Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol (1991) 0.99
Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol (1984) 0.99
Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol (1999) 0.99
Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol (1998) 0.99
Inaccuracy of Dubowitz gestational age in low birth weight infants. Obstet Gynecol (1984) 0.98
The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population. Am J Obstet Gynecol (1995) 0.98
A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol (1987) 0.98
A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol (1998) 0.97
Early and late intraventricular hemorrhage: the role of obstetric factors. Obstet Gynecol (1992) 0.97
Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol (1999) 0.96
Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res (2000) 0.96
Outcome after successful resuscitation of babies born with apgar scores of 0 at both 1 and 5 minutes. Am J Obstet Gynecol (2000) 0.95
Diagnostic ultrasound for detection of intrauterine growth retardation. Am J Obstet Gynecol (1976) 0.95